InvestorsHub Logo
Followers 3
Posts 928
Boards Moderated 0
Alias Born 03/30/2021

Re: Devolution post# 3633

Monday, 07/25/2022 9:09:30 AM

Monday, July 25, 2022 9:09:30 AM

Post# of 5265
Cross and Company either really believes in AXIM ability to turn a profit on Dry Eye lateral flow tests or they have deep deep pockets and need to show some tax losses next year.

Either way, Cross and Company is investing heavily in AXIM Biotech.


Interesting to say the least.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News